Browse Data and Analysis
Filter
Search Data and Analysis
- 19 results found
- (-) South Korea
- (-) Grenada
- (-) New Technologies
- Clear all
In September 2024, a National Assembly member submitted a draft revision of the Act on Transboundary Movements of Living Modified Organisms, commonly referred to as the LMO Act.
Korea has not finalized the May 2021 revisions of its Living Modified Organism (LMO) Act, which defines Korea’s regulatory policies for products developed through innovative technologies including genome editing.
With international funding to develop and implement biosafety regulatory systems drying up in 2019, Caribbean biosafety regulatory efforts remain in idle mode. The region is seeking further funding from the United Nations Environmental Program/Global...
Korea is in the process of drafting a proposal to revise its existing Living Modified Organism (LMO) Act to cover products of innovative biotechnologies, including genome edited products.
In April 2019, the Rural Development Administration (RDA) announced the creation of its Center to Commercialize New Breeding Technologies.
Many Caribbean Community (CARICOM) Member States have undertaken efforts to comply with their obligations under the Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity....
This report provides minimal updates compared to the previous year’s report.
After 10 years under the Living Modified Organism (LMO) Act, Korea plans to improve and revise the LMO Act to address stakeholders’ concerns.
Many Caribbean Community (CARICOM) Member States have engaged in efforts to comply with their obligations under the Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity....
In February 2017, Korea implemented new biotech labeling requirements for any food with detectable biotech ingredients. In May 2017, the National Seed Management Agency (NSMA) found....
Biotech regulations have been virtually non-existent in the Caribbean. However, that may change in the years ahead....
Beginning February 4, 2017, Korea’s Ministry of Food and Drug Safety began enforcing biotech labeling requirements that were finalized on February 3, 2016.